Supplier
Biogen Idec Limited public sector contracts
- Contracts won
- 5
- In the last 12 months
- 2
- Buyers
- 3
- Value, last 12 months
- £1.53bn
Values as award notices state them; frameworks can include a ceiling rather than money spent.
Contracts won
| Contract | Trade | Value | Bids | Awarded |
|---|---|---|---|---|
| NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 NHS England · 4 of 2 lots · ends 31 Aug 2028 | Medical equipment and supplies | — | — | 15 Jun 2026 |
| NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 NHS England · 3 of 2 lots · ends 31 Aug 2028 | Medical equipment and supplies | — | — | 1 Jun 2026 |
| Branded and Biosimilar Ophthalmology | Medical equipment and supplies | — | 3 | — |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 NHS England · ends 31 May 2027 | Medical equipment and supplies | — | — | — |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 18 | Medical equipment and supplies | — | — | — |
Contracts ending in the next 12 months
These are often re-tendered, so this is when competitors start preparing.
- NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025NHS England · ends 31 May 2027
- NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS England · ends 31 August 2027
Main buyers
Contracts won from each
Trades
Contracts won in each
Data from public contract notices on Find a Tender and Contracts Finder. Something wrong? Tell us and we will correct it. We correct errors, but do not remove public award data.